Novavax Inc. said Monday its experimental Covid-19 vaccine is starting the second phase of testing to see if it can safely protect against the new coronavirus. The vaccine candidate is the latest to move a crucial step closer to wide use, behind a handful of shots that have already started the final stage of testing and one developed in Russia that the government there cleared after limited study.

Source: Wall Street Journal August 17, 2020 06:22 UTC